Nuclear Medicine: Page 18

GE, Lantheus highlight flurpiridaz trial results

By AuntMinnie.com staff writers

A phase III trial found that Lantheus Medical Imaging's flurpiridaz F-18 investigational PET radiopharmaceutical outperformed SPECT myocardial perfusion imaging in patients with suspected coronary artery disease.

September 12, 2022

Is scientific fraud rife in nuclear medicine journals?

By Will Morton

Scientific fraud may be a problem in nuclear medicine research journals, says a group in the Netherlands that conducted a recent global survey on the issue. Results were published September 8 in the Journal of Nuclear Medicine.

September 11, 2022

Interest in nuclear medicine research dips among residents

By Will Morton

Nuclear medicine's best bet to attract more physicians to the field may be to get its hooks into residents interested in recent clinical advances, according to a study published September 1 in Academic Radiology.

September 8, 2022

Health Canada approves Pluvicto for prostate cancer treatment

By AuntMinnie.com staff writers

Health Canada has approved lutetium-177 prostate-specific membrane antigen radioligand therapy (Pluvicto, Novartis) for the treatment of patients with metastatic prostate cancer.

September 7, 2022

ASNC published new guide on hybrid imaging

By AuntMinnie.com staff writers

The American Society of Nuclear Cardiology (ASNC) and three partner societies have offered new guidelines for the use of CT in hybrid nuclear/CT cardiac imaging, as published September 2 in the Journal of Nuclear Cardiology.

September 5, 2022

First patient in Oncoinvent trial treated for colorectal cancer

By AuntMinnie.com staff writers

Norwegian radiopharmaceutical developer Oncoinvent is highlighting that the first colorectal cancer patient has been treated in a clinical trial of the company's Radspherin drug candidate.

August 25, 2022

Anthropomorphic phantoms from Sun Nuclear bound for space

By AuntMinnie.com staff writers

A pair of Sun Nuclear anthropomorphic phantoms will travel aboard NASA's Orion spacecraft as part of an upcoming mission aimed at enabling human exploration to the moon and Mars.

August 24, 2022

AtomVie raises $40M to build new radiopharmaceutical facility

By AuntMinnie.com staff writers

AtomVie Global Radiopharma has received at least $40 million in financing that will be used to build a new facility to expand its radiopharmaceutical manufacturing.

August 23, 2022

NorthStar inks supply deal with Aktis Oncology

By AuntMinnie.com staff writers

NorthStar Medical Radioisotopes has inked a long-term supply agreement with Aktis Oncology for NorthStar's actinium-225 (Ac-225) therapeutic radioisotope.

August 22, 2022

Shine names D'Orazio CEO of Phoenix

By AuntMinnie.com staff writers

Shine Technologies recently named Tom D'Orazio as the CEO of its industrial imaging arm, Phoenix. Both companies are wholly owned subsidiaries of Illuminated Holdings.

August 18, 2022

Bolivia opens nuclear medicine research center

By Will Morton

Bolivia has begun pilot operations at a nuclear research center on the outskirts of La Paz -- a location more than 13,000 feet above sea level. The facility is the highest-altitude site in the world producing radioisotopes for use in medicine, according to an August 9 report in World Nuclear News.

August 11, 2022

Lantheus posts healthy 2022 Q2 revenues

By AuntMinnie.com staff writers

Lantheus Medical Imaging parent company Lantheus Holdings reported a 121.4% increase in revenue in its 2022 second quarter, as well as net income compared to a net loss in 2021.

August 7, 2022

Previous Page

Page 18 of 438

Next Page